| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute Antibody-Mediated Rejection in Living ABO-Incompatible Kidney Transplantation: Long-Term Impact and Risk Factors
|
Toki, D.
|
|
|
9 |
3 |
p. 567-577
|
artikel
|
| 2 |
Arms, Ovaries and Tracheas…What Next?
|
|
|
|
9 |
3 |
p. 438
|
artikel
|
| 3 |
‘Chimeric’ Grafts Assembled from Multiple Allodisparate Donors Enjoy Enhanced Transplant Survival
|
Saban, D.R.
|
|
|
9 |
3 |
p. 473-482
|
artikel
|
| 4 |
Donor and Recipient Origin of Mesenchymal and Endothelial Cells in Chronic Renal Allograft Remodeling
|
Rienstra, H.
|
|
|
9 |
3 |
p. 463-472
|
artikel
|
| 5 |
Effect of Comorbidity Adjustment on CMS Criteria for Kidney Transplant Center Performance
|
Weinhandl, E.D.
|
|
|
9 |
3 |
p. 506-516
|
artikel
|
| 6 |
Ex vivo Inhibition of NF-κB Signaling in Alloreactive T-cells Prevents Graft-Versus-Host Disease
|
O’Shaughnessy, M.J.
|
|
|
9 |
3 |
p. 452-462
|
artikel
|
| 7 |
18F-FDG-Uptake of Hepatocellular Carcinoma on PET Predicts Microvascular Tumor Invasion in Liver Transplant Patients
|
Kornberg, A.
|
|
|
9 |
3 |
p. 592-600
|
artikel
|
| 8 |
Follicular Bronchiolitis: A Rare Cause of Bronchiolitis Obliterans Syndrome After Lung Transplantation: A Case Report
|
Vos, R.
|
|
|
9 |
3 |
p. 644-650
|
artikel
|
| 9 |
Formal Policies and Special Informed Consent Are Associated with Higher Provider Utilization of CDC High-Risk Donor Organs
|
Kucirka, L.M.
|
|
|
9 |
3 |
p. 629-635
|
artikel
|
| 10 |
Identifying Specific Causes of Kidney Allograft Loss
|
El-Zoghby, Z.M.
|
|
|
9 |
3 |
p. 527-535
|
artikel
|
| 11 |
ID2-VEGF-related Pathways in the Pathogenesis of Kaposi’s Sarcoma: A Link Disrupted by Rapamycin
|
Stallone, G
|
|
|
9 |
3 |
p. 558-566
|
artikel
|
| 12 |
Kidney Transplantation Decreases the Level and Procoagulant Activity of Circulating Microparticles
|
Al-Massarani, G.
|
|
|
9 |
3 |
p. 550-557
|
artikel
|
| 13 |
Kidney Transplantation in Previous Heart or Lung Recipients
|
Lonze, B.E.
|
|
|
9 |
3 |
p. 578-585
|
artikel
|
| 14 |
Mycophenolate Mofetil Monotherapy for Severe Side Effects of Calcineurin Inhibitors Following Liver Transplantation
|
Dharancya, S.
|
|
|
9 |
3 |
p. 610-613
|
artikel
|
| 15 |
News and issues that affect organ and tissue transplantation
|
Pondrom, Sue
|
|
|
9 |
3 |
p. 437-438
|
artikel
|
| 16 |
Perceptions of Transitional Care Needs and Experiences in Pediatric Heart Transplant Recipients
|
Anthony, S.J.
|
|
|
9 |
3 |
p. 614-619
|
artikel
|
| 17 |
Positive Cross-Match Living Donor Kidney Transplantation: Longer-Term Outcomes
|
Haririan, A.
|
|
|
9 |
3 |
p. 536-542
|
artikel
|
| 18 |
Predictive Ability of Pretransplant Comorbidities to Predict Long-Term Graft Loss and Death
|
Machnicki, G.
|
|
|
9 |
3 |
p. 494-505
|
artikel
|
| 19 |
Racial Disparity Trends for Graft Failure in the US Pediatric Kidney Transplant Population, 1980—2004
|
Chavers, B.M.
|
|
|
9 |
3 |
p. 543-549
|
artikel
|
| 20 |
Renal Allografts with IF/TA Display Distinct Expression Profiles of Metzincins and Related Genes
|
Rödder, S.
|
|
|
9 |
3 |
p. 517-526
|
artikel
|
| 21 |
Resource Utilization of Living Donor Versus Deceased Donor Liver Transplantation Is Similar at an Experienced Transplant Center
|
Lai, J.C.
|
|
|
9 |
3 |
p. 586-591
|
artikel
|
| 22 |
Serum Autoantibodies Against Cytochrome P450 2E1 (CYP2E1) Predict Severity of Necroinflammation of Recurrent Hepatitis C
|
Rigamonti, C.
|
|
|
9 |
3 |
p. 601-609
|
artikel
|
| 23 |
Stability of Alemtuzumab for Low-Dose Induction and Test Doses
|
Vermeulen, L.C.
|
|
|
9 |
3 |
p. 651-652
|
artikel
|
| 24 |
The Early Course of Kidney Allograft Rejection: Defining the Time When Rejection Begins
|
Einecke, G.
|
|
|
9 |
3 |
p. 483-493
|
artikel
|
| 25 |
Therapeutic Targets in Liver Transplantation: Angiotensin II in Nonsteatotic Grafts and Angiotensin-(1—7) in Steatotic Grafts
|
Alfany-Fernandez, I.
|
|
|
9 |
3 |
p. 439-451
|
artikel
|
| 26 |
Valganciclovir Dosing According to Body Surface Area and Renal Function in Pediatric Solid Organ Transplant Recipients
|
Vaudrya, W
|
|
|
9 |
3 |
p. 636-643
|
artikel
|
| 27 |
Viral Nucleic Acid Testing (NAT) and OPO-Level Disposition of High-Risk Donor Organs
|
Kucirka, L.M.
|
|
|
9 |
3 |
p. 620-628
|
artikel
|
Tijdschrift beschrijving